Advances in Pulmonary Hypertension
Advances in Pulmonary Hypertension is PHA’s quarterly medical journal, directed by an editorial board of renowned experts with the oversight of PHA’s Scientific Leadership Council. Its mission is to help physicians in their clinical decision-making by informing them of important trends affecting their practice and providing an analysis of the impact of new findings in peer-reviewed publications. Each article is reviewed and approved by members of the Editorial Advisory Board.
The objectives of Advances are to:
• Provide up-to-date information regarding diagnosis, pathophysiology, and treatment of pulmonary hypertension (PH)
• Serve as a forum for presentation and discussion of important issues in the field, including new paradigms of disease understanding and investigational trial design
• Recognize and preserve the rich history of individuals who have made major contributions to the field via dedication to patient care, innovative research and furthering efforts to find a PH cure